State Senator Rita Parks said concessions were made to ensure the regulation of PBMs stays with the Board of Pharmacy. The Senate Public Health Committee adopted a strike-all amendment to the House’s ...
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade 1-3 HS often emerges around puberty, underscoring importance of early ...
ORKA-001 EVERLAST-A 16-week data now expected in 2Q 2026 following rapid enrollment, with longer-term follow-up data expected in 2H 2026 ORCA-SURGE Phase 2 trial of ORKA-002 in psoriasis initiated wit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results